On June 18, 2025 Chardan Senior Research Analyst, Geulah Livshits, PhD, will moderate the panel "In Vivo CARs: Unlocking the Potential of Immune Cell Programming in Oncology and Beyond". Panelists include Adrian Bot, MD, PhD, Chief Scientific Officer, Capstan Therapeutics; Ryan Crisman, PhD, CTO, Umoka Biopharma, Inc.; Kevin Friedman, PhD, CEO, Kelonia Therapeutics; Daniel Getts, PhD, CEO, Myeloid Therapeutics; and Phil Johnson, MD, CEO, Interius BioTherapeutics.

Learn more here: https://convention.bio.org/program-1/vivo-cars-unlocking-potential-immune-cell-programming-oncology-beyond